Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beicheng Sun

Showing results (181-190 of 203) with videos related to

Pageof 21
Sort By:
Ebiomedicine|October 23, 2018
Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failureGuoxiang Xie, Xiaoning Wang, Runqiu Jiang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 5, 2014
CD24 single nucleotide polymorphisms and cancer riskShushan Yan, Donghua Xu, Tao Jiang, et al.
Ebiomedicine|March 22, 2021
Conjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesisGuoxiang Xie, Runqiu Jiang, Xiaoning Wang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 15, 2013
MTHFR C677T polymorphism contributes to the risk for gastric cancerShushan Yan, Donghua Xu, Pingping Wang, et al.
Journal of Hepatology|July 20, 2023
The XOR-IDH3α axis controls macrophage polarization in hepatocellular carcinomaYijun Lu, Qikai Sun, Qifei Guan, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 13, 2023
TNFR2 is a potent prognostic biomarker for post-transplant lung metastasis in patients with hepatocellular carcinomaHuigang Li, Zuyuan Lin, Jianyong Zhuo, et al.
Molecular Cancer|September 5, 2020
Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinomaJiajie Hou, He Zhang, Jun Liu, et al.
Molecular Cancer|November 19, 2019
YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinomaJiajie Hou, He Zhang, Jun Liu, et al.
Oncogene|January 12, 2024
TKT-PARP1 axis induces radioresistance by promoting DNA double-strand break repair in hepatocellular carcinomaLongpo Geng, Mingming Zhu, Dongjun Luo, et al.
Journal of Hepatology|August 4, 2025
Targeting xanthine oxidoreductase reverses resistance to EGFR tyrosine kinase inhibitors in intrahepatic cholangiocarcinomaJianbo He, Minglu Zhang, Yuze Shi, et al.
Pageof 21

Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
Ebiomedicine|October 23, 2018
Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failureGuoxiang Xie, Xiaoning Wang, Runqiu Jiang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 5, 2014
CD24 single nucleotide polymorphisms and cancer riskShushan Yan, Donghua Xu, Tao Jiang, et al.
Ebiomedicine|March 22, 2021
Conjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesisGuoxiang Xie, Runqiu Jiang, Xiaoning Wang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 15, 2013
MTHFR C677T polymorphism contributes to the risk for gastric cancerShushan Yan, Donghua Xu, Pingping Wang, et al.
Journal of Hepatology|July 20, 2023
The XOR-IDH3α axis controls macrophage polarization in hepatocellular carcinomaYijun Lu, Qikai Sun, Qifei Guan, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 13, 2023
TNFR2 is a potent prognostic biomarker for post-transplant lung metastasis in patients with hepatocellular carcinomaHuigang Li, Zuyuan Lin, Jianyong Zhuo, et al.
Molecular Cancer|September 5, 2020
Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinomaJiajie Hou, He Zhang, Jun Liu, et al.
Molecular Cancer|November 19, 2019
YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinomaJiajie Hou, He Zhang, Jun Liu, et al.
Oncogene|January 12, 2024
TKT-PARP1 axis induces radioresistance by promoting DNA double-strand break repair in hepatocellular carcinomaLongpo Geng, Mingming Zhu, Dongjun Luo, et al.
Journal of Hepatology|August 4, 2025
Targeting xanthine oxidoreductase reverses resistance to EGFR tyrosine kinase inhibitors in intrahepatic cholangiocarcinomaJianbo He, Minglu Zhang, Yuze Shi, et al.
Pageof 21